What is Northrop Grumman's latest dividend and current dividend yield?

What were the key takeaways from Northrop Grumman’s earnings call?

What were the key takeaways from Northrop Grumman's earnings call?

What guidance did Northrop Grumman's management provide for the next earnings period?

What is Northrop Grumman's gross profit margin?

What factors drove the changes in Northrop Grumman's revenue and profit?

Did Northrop Grumman beat or miss consensus estimates last quarter?

What is the revenue and EPS growth rate for Northrop Grumman year over year?

- **Record 2025 Performance**: $42B sales, $95B backlog, $3.3B free cash flow.
- **Strategic Growth Drivers**: B-21 acceleration ($2-3B investment), 150 SDA satellites, munitions capacity tripling.
- **2026 Outlook**: $43.5-44B sales, $27.40-27.90 EPS, $3.1-3.5B free cash flow.
- **Key Risks**: B-21 timing uncertainty, supply chain constraints.
- **Shareholder Value**: 26% FCF growth, disciplined capital allocation.

**【CEO Summary Section】**
- Northrop Grumman delivered record 2025 results with $42 billion in sales, exceeding high-end guidance. 
- Backlog reached $95 billion, driven by $46 billion in net awards, including 150 SDA satellites and B-21 program acceleration.
- Strategic focus on unmanned systems (Project Talon), missile defense (IBC), and munitions capacity expansion (SRM production tripling by 2027).
- 2026 outlook: $43.5-44B sales (+mid-single digits), $27.40-27.90 EPS, $3.1-3.5B free cash flow.

**【CFO Financial Commentary】**
- Q4 2025: $11.7B sales (+10% YoY), $7.23 EPS, $3.3B free cash flow (+26% YoY).
- Segment margins: Aeronautics 9%, Defense Systems 10%, Space 11.3%.
- 2026 capital spend $1.65B (4% of sales) for capacity expansion.
- Pension funded at 106%, CAS recoveries $245M.

**【Q&A Highlights】**
- **B-21 Acceleration**: $2-3B investment over multi-years, 2027+ revenue impact.
- **International Growth**: IBCS interest from 20+ countries, 20%+ international sales growth.
- **CapEx & Cash**: 2026 CapEx up 25%, dividend policy update in Q2.
- **Supply Chain**: Partnering with government to address rare earth, raw material shortages.

Northrop Grumman Corporation (NOC) Q4 2025 Earnings Call Transcript

- **Revenue and Margin Expansion**: Q3 revenue of $10.4B (+4% YoY) with segment operating margin of 12.3%, up 80bps YoY. Free cash flow up 72% YoY to $1.3B.
- **Strategic Program Wins**: B-21 book-to-bill of 1.17, IBCS 32/32 live-fire success, and GEM 63XL supporting Amazon Kuiper launches.
- **Growth Drivers**: Mid-single-digit organic growth in 2026, with $3.1B-$3.5B free cash flow (excluding F/A-XX/B-21 acceleration).
- **Risks and Opportunities**: Government shutdown delays, but potential upside from B-21 production acceleration and F/A-XX win.
- **Investment Payoff**: $4B+ in capex and $2.1B in R&D driving long-term growth in missile defense, AI, and attritable systems.

**【CEO Summary Section】**
- **Revenue Growth and Organic Expansion**: Q3 2025 revenue reached $10.4 billion, up 4% year-over-year, with organic growth of 5%. International sales grew 32% year-over-year, driven by strong demand in missile defense and advanced air systems.
- **Segment Performance**: Aeronautics ($3.1B) saw 6% growth from TACAMO and F-35 programs; Mission Systems ($2.1B) delivered double-digit growth on advanced microelectronics; Space Systems ($2.7B) showed sequential growth despite headwinds from legacy programs.
- **Key Programs**: B-21 achieved a book-to-bill of 1.17, with Lot 3 and 5 advanced procurement awards expected in Q4. IBCS completed 32 successful live-fire tests and is being deployed internationally. GEM 63XL rocket motors supported Amazon's Kuiper satellite launches.
- **Strategic Investments**: $2.1B in R&D for AI, multifunction sensors, and attritable systems; $4B+ in capital expenditures for production capacity in munitions, propulsion, and microelectronics.
- **2026 Outlook**: Mid-single-digit organic growth across all segments, with segment operating margins in the low to mid-11% range. Free cash flow projected at $3.1B-$3.5B, excluding potential wins on F/A-XX or B-21 production acceleration.

**【CFO Financial Commentary】**
- **Top Line**: Q3 sales of $10.4B (+4% YoY) driven by Aeronautics (+6%), DS (+14%), and Mission Systems (+10%). Space Systems growth offset legacy program declines.
- **Bottom Line**: Segment operating margin expanded to 12.3% (up 80bps YoY), with strong performance in DS (11.4%), Mission Systems (16.7%), and Space Systems (11%). Diluted EPS rose 10% to $7.67, supported by mark-to-market gains on securities.
- **Guidance Updates**: Full-year sales revised to $41.7B-$41.9B, with Q4 growth of ~8% at midpoint. EPS increased to $25.65-$26.05, reflecting lower corporate expenses and higher pension income. Free cash flow reaffirmed at $3.05B-$3.35B.
- **2026 Financial Health**: Segment operating income growth expected despite no repeat of large EAC adjustments. Net pension income projected to increase modestly based on asset returns and discount rates.

**【Q&A Highlights】**
- **B-21 Production Rate**: Discussions with the Air Force on accelerating production could drive incremental revenue and require capital investments, with long-term margin accretion potential.
- **F/A-XX Competition**: Development program would be cost-plus with lower margins initially, but could become accretive over time if awarded.
- **Supply Chain Resilience**: U.S.-based microelectronics foundries mitigate rare earth dependency, with government support for domestic manufacturing.
- **IBCS International Growth**: Poland deployment and U.S. homeland defense contracts position IBCS for double-digit growth in 2026.
- **Government Shutdown Impact**: Minimal impact on 2025 guidance, but prolonged shutdown could delay program awards and cash collections.
- **Missile Defense Expansion**: Investments in solid rocket motor capacity (GEM 63XL, 21-inch SRMs) position Northrop to win new missile programs under the Golden Dome architecture.

Northrop Grumman Corporation (NOC) Q3 2025 Earnings Call Transcript

- **Record Q2 Performance**: $10.4B revenue, 11.8% segment margin, $8.15 EPS (+28% YoY).
- **Strategic Programs**: B-21 production funding, Sentinel restructure, and Golden Dome for America growth.
- **International Expansion**: 18% YoY sales growth, 1.4x book-to-bill ratio.
- **Financial Strength**: Free cash flow guidance raised to $3.05B-$3.35B; 12% dividend increase.
- **Tax Impact**: 17%+ tax rate but $200M long-term cash benefit.

**【CEO Summary Section】**
- **Q2 2025 Performance**: Revenue of $10.4 billion (+1% YoY), segment operating margin of 11.8%, and EPS of $8.15 (+28% YoY). All segments contributed to sequential growth of 9%.
- **Key Programs**: 
  - **B-21**: $4.5 billion in reconciliation funding for production capacity expansion; discussions with Air Force on accelerated ramp.
  - **Sentinel**: Positive EAC adjustment, resumption of Command & Launch segment work, and $1.5 billion FY26 funding.
  - **Golden Dome for America**: Testing space-based interceptors; potential growth in missile defense and hypersonic capabilities.
- **International Growth**: 18% YoY sales growth, driven by IBCS, munitions, and airborne systems in Europe and Middle East.
- **Investments**: $1 billion in solid rocket motors (25,000 units/year by 2029) and Beacon testbed for autonomous systems.
- **Shareholder Returns**: $900M stock buybacks YTD, 12% dividend increase (22nd consecutive annual hike).

**【CFO Financial Commentary】**
- **Top Line**: Full-year organic sales guidance of +3%, with Q2 sales up 9% sequentially.
- **Margins**: Segment operating margin rate of 11.4% in H2, driven by MS (+22% YoY) and DS (+9% YoY).
- **EPS Guidance**: Increased to $25.00-$25.40, reflecting higher margins offset by 17%+ tax rate due to R&D tax credit changes.
- **Cash Flow**: Free cash flow guidance raised to $3.05B-$3.35B, driven by inventory liquidations and milestone payments.

**【Q&A Key Highlights】**
- **B-21 Acceleration**: Discussions with Air Force on production ramp requiring company investment for improved returns on LRIP/NTE lots.
- **Sentinel Progress**: EAC adjustment reflects confidence in achieving performance incentives; Command & Launch segment design underway.
- **International Strategy**: 1.4x book-to-bill ratio; partnerships (e.g., UK, South Korea) for co-production and technology transfer.
- **Space Systems**: FY26 growth expected from Golden Dome for America; NASA programs (SLS, HALO) account for 3% of sales.
- **Tax Impact**: $200M cash tax benefit over 3 years, offsetting 21% Q3 tax rate.


Northrop Grumman Corporation (NOC) Q2 2025 Earnings Call Transcript

- **B-21 Program Challenges**: $477M loss from production process changes, but NTE units remain profitable
- **International Expansion**: 11% Q1 sales growth, 1.45x book-to-bill, IBCS interest from 12+ countries
- **AI Innovation**: Partnering with commercial leaders to enhance mission systems with AI
- **Supply Chain Strength**: <5% non-U.S. sourcing, 200M+ cost efficiencies through digital transformation
- **Segment Growth**: 
  - AS: Mid-single digit
  - MS: 6%
  - DS: Double-digit
  - Space: $11B sales


**【CEO Opening Remarks】**
- Q1 2025 revenue of $9.5B reflects 7% YoY decline due to B-21 production delays and material timing. Backlog reached $92.8B, driven by strong international bookings (14% of sales). 
- B-21 program incurred $477M pre-tax loss from higher manufacturing costs and material price increases. Progress on first 2 LRIP lots and readiness for Air Force delivery.
- Key program milestones: 
  - Sentinel static fire test validates solid rocket motor design
  - IBCS awarded $500M for AI-enabled software expansion
  - 2 additional Triton aircraft delivered to U.S. Navy, with 2 more for Australia
  - Poland signs $745M AARGM-ER missile contract
- Global defense spending growth driven by U.S. defense budget flexibility ($150B+ potential) and international partners (e.g., Middle East, Asia-Pacific).

**【CFO Financial Review】**
- Q1 2025 Results:
  - Sales: $9.5B (-7% YoY)
  - Segment Operating Income: $562M (6% OM rate)
  - EPS: $1.08 (Non-GAAP), below prior year due to B-21 adjustment
  - Operating cash outflow: $1.5B (seasonal)
- Guidance Update:
  - Full year sales: $42-42.5B (3-4% organic growth)
  - Free cash flow: $2.85-3.25B
  - Segment margin targets: 
    - AS: low-mid 6%
    - MS: mid 14%
    - DS: high single digits
    - Space: 11-13%
- B-21 cash impact: $477M charge spread over 2026-2028, no material 2025 impact

**【Q&A Key Takeaways】**
1. **B-21 Program Risks**:
   - Process changes to enable higher production rates caused $477M loss
   - Material cost increases driven by macroeconomic factors
   - NTE units (100+ aircraft) expected to remain profitable
2. **International Growth**:
   - Q1 international sales up 11%, book-to-bill 1.45x
   - IBCS interest from 12+ countries, Poland expanding to near-range defense
   - AARGM-ER approved for export to multiple nations
3. **AI & Innovation**:
   - Partnering with commercial AI leaders (e.g., Nvidia) to enhance mission systems
   - AI-driven capabilities in IBCS, EW, and sensor fusion
4. **Supply Chain Resilience**:
   - <5% of spend sourced outside U.S., long-term contracts mitigate tariff risk
   - 200M+ in cost efficiencies through digital ecosystem, facility optimization
5. **Segment Outlook**:
   - AS: Mid-single digit growth, B-21 LRIP ramp
   - MS: 6% growth, Saber, EW, and marine programs
   - DS: Double-digit growth, IBCS, Sentinel, and munitions
   - Space: $11B sales, restricted domain wins


Northrop Grumman (NOC)-22 Apr 25-2025 Q1 Earnings call transcript

- **Record Backlog & Growth**: 2024 ends with $91.5B backlog (1.23x book-to-bill), 4.4% organic revenue growth, and $2.6B free cash flow. 2025 targets 3-4% growth and 15%+ FCF growth.
- **Strategic Shifts**: Exiting training services ($327M sale) to focus on missile defense, with microelectronics business growing 20% in 2024.
- **Margin Expansion**: 2024 segment margin 11.1%, 2025 expects 10bp expansion via cost efficiency and international mix.
- **Key Programs**: B-21 and IBCS drive 2025 growth, with Poland's $900M IBCS booking highlighting international momentum.
- **Liquidity & Returns**: $4.4B cash balance, $1.5B 2025 CapEx, and 100% FCF return to shareholders.


**【CEO Summary Section】**
- Northrop Grumman achieved record backlog of $91.5 billion in 2024, driven by a 1.23x book-to-bill ratio and $900 million in Poland's IBCS program. International bookings grew at 1.4x, with expectations for faster international sales growth in 2025.
- 2024 revenue increased 4.4% organically, with free cash flow up 25% to $2.6 billion. 2025 guidance includes 3-4% organic growth and double-digit free cash flow growth.
- Strategic focus on advanced manufacturing, AI integration, and microelectronics innovation (e.g., Terahertz Microchip) to maintain technology differentiation.
- Exiting training services business ($327M sale) to refocus on core defense and missile systems.

**【CFO Financial Commentary】**
- 2024 GAAP net income: $420M; Non-GAAP EPS: $26.08 (exceeding guidance). 2025 EPS guidance: $28.5 (midpoint), driven by $205M gain from training services sale and 7%+ free cash flow growth.
- Segment operating margin expanded to 11.1%, with 2025 margin expansion of 10 basis points. Aeronautics, Defense Systems, and Mission Systems all project margin improvements.
- 2025 capital expenditures: $1.5B, supporting advanced manufacturing and program ramps (e.g., B-21, IBCS).

**【Q&A Highlights】**
- **B-21 & GBSD Growth**: Both programs contribute modestly to 2025 growth (~<10% of sales), with B-21 production ramping gradually.
- **Iron Dome Potential**: Company offers end-to-end missile defense solutions (e.g., left-of-launch disruption, hypersonic interceptors) aligned with U.S. homeland defense needs.
- **Space Segment Challenges**: $900M headwind from restricted programs in 2025, but expects Space segment to return to growth by year-end with strategic missile and propulsion systems.
- **International Expansion**: Poland's IBCS and E-2D programs drive double-digit international growth, with 2025 bookings expected to exceed U.S. sales growth.
- **Free Cash Flow Outlook**: 2025 FCF >15% growth, supported by $2.5B R&D/CapEx and 100% shareholder returns via buybacks/dividends.


Actual																5.15	6.01	5.89	6.59	6.57	6.42	6.63	6	6.1	6.06	5.89	7.5	5.5	5.34	6.18	6.27	6.32	6.36	7	6.39	3.32	8.15	7.67	7.23
Forecast																5.5066	5.3444	5.6233	5.7588	5.4801	5.8354	5.9911	5.9601	5.962	6.1028	6.1121	6.6267	5.0954	5.3262	5.8126	5.8036	5.778	5.9274	6.0834	6.3535	6.2426	6.9223	6.4434	6.98	6.0295
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-6.48%	+12.45%	+4.74%	+14.43%	+19.89%	+10.02%	+10.66%	+0.67%	+2.31%	-0.70%	-3.63%	+13.18%	+7.94%	+0.26%	+6.32%	+8.04%	+9.38%	+7.30%	+15.07%	+0.57%	-46.82%	+17.74%	+19.04%	+3.58%	0.00%

Actual	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	8.62B	8.88B	9.08B	10.21B	9.16B	9.15B	8.72B	8.64B	8.80B	8.80B	8.97B	10.03B	9.30B	9.58B	9.78B	10.64B	10.13B	10.22B	10.00B	10.69B	9.47B	10.35B	10.42B	11.71B	--
Forecast	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	8.53B	8.63B	8.86B	9.27B	8.53B	8.77B	8.95B	9.00B	8.88B	9.07B	9.13B	9.67B	9.18B	9.36B	9.58B	10.43B	9.77B	10.02B	10.18B	10.97B	9.92B	10.06B	10.72B	11.61B	9.75B
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	+1.11%	+2.99%	+2.49%	+10.18%	+7.32%	+4.36%	-2.53%	-3.97%	-0.90%	-2.99%	-1.72%	+3.80%	+1.33%	+2.35%	+2.02%	+1.96%	+3.77%	+2.00%	-1.81%	-2.55%	-4.57%	+2.86%	-2.75%	+0.85%	0.00%

NOC

NOC fundamentals

NOC Q1 2026 Earnings Preview

Earnings Call

You can ask Aime

NOC

NOC fundamentals

NOC Q1 2026 Earnings Preview

Earnings Call

NOC Earnings Call Summary for Q1/2026Upcoming9:30 AM on Apr 21, 2026

NOC Earnings Call Summary for Q4/20259:30 AM on Jan 27, 2026

NOC Earnings Call Summary for Q3/20259:30 AM on Oct 21, 2025

NOC Earnings Call Summary for Q2/20259:30 AM on Jul 22, 2025

NOC Earnings Call Summary for Q1/20259:30 AM on Apr 22, 2025

You can ask Aime